{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:14:18Z","timestamp":1787170458520,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DOPPS programs"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic pain significantly impacts health-related quality of life (HRQOL) in patients with non-dialysis chronic kidney disease (ND-CKD), yet the management of pain in this population is challenging. We hypothesized that analgesic prescription practices vary internationally, influencing the pain experience and HRQOL of patients with stage 3\u20135 ND-CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This descriptive, observational, multinational cohort study utilized data from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps), enrolling adult patients from nephrology practices in Brazil, France and the USA between 2013 and 2020. Analgesic prescriptions within 6\u00a0months before HRQOL assessment were categorized as non-steroidal anti-inflammatory drugs (NSAIDs), opioids or other analgesics. HRQOL was measured using the Kidney Disease Quality of Life Short Form, assessing multiple subdomains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3945 patients, analgesics were most frequently prescribed in the USA across all CKD stages, with opioids prescribed nearly twice as often compared with Brazil and France. NSAIDs are frequently prescribed in Brazil, including in advanced CKD stages, contrasting sharply with practices in France and the USA. Higher reported pain intensity consistently correlated with poorer outcomes across all HRQOL subdomains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies considerable international variability in pain reporting and analgesic prescription patterns in patients with stage 3\u20135 ND-CKD. Randomized controlled trials evaluating the efficacy and safety of analgesics are warranted to improve key patient-reported outcomes such as pain in patients with ND-CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf346","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:04:14Z","timestamp":1765458254000},"source":"Crossref","is-referenced-by-count":1,"title":["International variations in chronic kidney disease patients\u2019 pain experience and its management"],"prefix":"10.1093","volume":"19","author":[{"given":"Rupesh","family":"Raina","sequence":"first","affiliation":[{"name":"Akron Children\u2019s Hospital Department of Nephrology, , Akron, OH \u00a0","place":["USA"]},{"name":"Akron Nephrology Associates\/Cleveland Clinic Akron General Medical Center , Akron, OH \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Nair","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine , Cleveland, OH \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Kumar","sequence":"additional","affiliation":[{"name":"University School , Hunting Valley, OH \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush","family":"Doshi","sequence":"additional","affiliation":[{"name":"Akron Nephrology Associates\/Cleveland Clinic Akron General Medical Center , Akron, OH \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-6487","authenticated-orcid":false,"given":"Natalia","family":"Alencar-de Pinho","sequence":"additional","affiliation":[{"name":"Center for Research in Epidemiology and Population Health, Paris-Saclay University, Paris-Sud University, Versailles Saint Quentin University, INSERM , Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Tu","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bieber","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[{"name":"Amiens-Picardie University Medical Center Pharmacoepidemiology Unit, Department of Clinical Pharmacology, , Amiens ,","place":["France"]},{"name":"MP3CV Laboratory, Jules Verne University of Picardie , Amiens ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-573X","authenticated-orcid":false,"given":"Christian","family":"Combe","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie Transplantation Dialyse Aph\u00e9r\u00e8se , CHU de Bordeaux, Univ. Bordeaux, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Reichel","sequence":"additional","affiliation":[{"name":"Nephrological Center , Villingen Schwenningen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Argyropoulos","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of New Mexico School of Medicine, University of New Mexico , Albuquerque, NM \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-852X","authenticated-orcid":false,"given":"Murilo","family":"Guedes","sequence":"additional","affiliation":[{"name":"Stanford University Department of Medicine, , Stanford, CA \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-6710","authenticated-orcid":false,"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"2026011003515796500_bib1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2215\/CJN.00600115","article-title":"Pain, analgesics, and safety in patients with CKD","volume":"10","author":"Davison","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011003515796500_bib2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/j.ajkd.2003.08.025","article-title":"Pain in hemodialysis patients: prevalence, cause, severity, and management","volume":"42","author":"Davison","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026011003515796500_bib3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ackd.2005.03.008","article-title":"Chronic pain in end-stage renal disease","volume":"12","author":"Davison","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026011003515796500_bib4","first-page":"294","article-title":"Pain prevalence in patients with chronic kidney disease","volume":"73","author":"Pham","year":"2010","journal-title":"Clin Nephrol"},{"key":"2026011003515796500_bib5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jpainsymman.2009.08.008","article-title":"Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients","volume":"39","author":"Davison","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"2026011003515796500_bib6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/ndt\/gfr355","article-title":"Pain, sleep disturbance and survival in hemodialysis patients","volume":"27","author":"Harris","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026011003515796500_bib7","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.2215\/CJN.00220114","article-title":"Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis","volume":"9","author":"Weisbord","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011003515796500_bib8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jpainsymman.2018.12.006","article-title":"Comparison of fatigue, pain, and depression in patients with advanced kidney disease and cancer\u2014symptom burden and clusters","volume":"57","author":"Jhamb","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026011003515796500_bib9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.kint.2023.05.019","article-title":"Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"104","author":"Mehrotra","year":"2023","journal-title":"Kidney Int"},{"key":"2026011003515796500_bib10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/MNH.0000000000000646","article-title":"Pain management in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Roy","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026011003515796500_bib11","doi-asserted-by":"publisher","first-page":"2054358120910329","DOI":"10.1177\/2054358120910329","article-title":"Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis","volume-title":"Can J Kidney Health Dis","author":"Davison","year":"2020"},{"key":"2026011003515796500_bib12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/204946370800100203","article-title":"Cultural influences on pain","volume-title":"Rev Pain","author":"Peacock","year":"2008"},{"key":"2026011003515796500_bib13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ajkd.2016.03.414","article-title":"The CKD Outcomes and Practice Patterns Study (CKDopps): rationale and methods","volume":"68","author":"Mariani","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026011003515796500_bib14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","article-title":"Development of the kidney disease quality of life (KDQOL) instrument","volume":"3","author":"Hays","year":"1994","journal-title":"Qual Life Res"},{"key":"2026011003515796500_bib15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12916-016-0775-3","article-title":"Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain","volume":"15","author":"Olsen","year":"2017","journal-title":"BMC Med"},{"key":"2026011003515796500_bib16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.kint.2021.03.041","article-title":"The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis","volume":"100","author":"Lambourg","year":"2021","journal-title":"Kidney Int"},{"key":"2026011003515796500_bib17","doi-asserted-by":"publisher","first-page":"2054358121993995","DOI":"10.1177\/2054358121993995","article-title":"The prevalence and severity of chronic pain in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"8","author":"Davison","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"2026011003515796500_bib18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3389\/fphar.2019.00932","article-title":"Neuropsychiatric disorders in chronic kidney disease","volume":"10","author":"Sim\u00f5es","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026011003515796500_bib19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/ckj\/sfx080","article-title":"2017 update on pain management in patients with chronic kidney disease","volume":"10","author":"Pham","year":"2017","journal-title":"Clin Kidney J"},{"key":"2026011003515796500_bib20","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.eclinm.2021.101198","article-title":"Global consumption of prescription opioid analgesics between 2009\u20132019: a country-level observational study","volume":"42","author":"Jayawardana","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026011003515796500_bib21","doi-asserted-by":"publisher","first-page":"e1910734","DOI":"10.1001\/jamanetworkopen.2019.10734","article-title":"Opioid prescribing after surgery in the United States, Canada, and Sweden","volume":"2","author":"Ladha","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026011003515796500_bib22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3122\/jabfm.2017.02.160299","article-title":"Comparison of opioid prescribing patterns in the United States and Japan: primary care physicians' attitudes and perceptions","volume":"30","author":"Onishi","year":"2017","journal-title":"J Am Board Fam Med"},{"key":"2026011003515796500_bib23","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2468-2667(22)00063-9","article-title":"Closing the global pain divide: balancing access and excess","volume":"7","author":"Knaul","year":"2022","journal-title":"Lancet Public Health"},{"key":"2026011003515796500_bib24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: are they safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2026011003515796500_bib25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2215\/CJN.04770610","article-title":"Opioid and benzodiazepine use in end-stage renal disease: a systematic review","volume":"6","author":"Wyne","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf346\/65838989\/sfaf346.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/1\/sfaf346\/65838989\/sfaf346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/1\/sfaf346\/65838989\/sfaf346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:52:04Z","timestamp":1768035124000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf346\/8377270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf346","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,11]]},"article-number":"sfaf346"}}